Danesi R - Search Results

1

Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.

Giovannetti E, Lemos C, Tekle C, Smid K, Nannizzi S, Rodriguez JA, Ricciardi S, Danesi R, Giaccone G, Peters GJ. Giovannetti E, et al. Among authors: danesi r. Mol Pharmacol. 2008 Apr;73(4):1290-300. doi: 10.1124/mol.107.042382. Epub 2008 Jan 10. Mol Pharmacol. 2008. PMID: 18187583

2

Cardiac toxicity and antitumor activity of 4'-deoxy-4'-iodo-doxorubicinol.

Danesi R, Marchetti A, Bernardini N, La Rocca RV, Bevilacqua G, Del Tacca M. Danesi R, et al. Cancer Chemother Pharmacol. 1990;26(6):403-8. doi: 10.1007/BF02994089. Cancer Chemother Pharmacol. 1990. PMID: 2171795

3

Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.

Danesi R, Nardini D, Basolo F, Del Tacca M, Samid D, Myers CE. Danesi R, et al. Mol Pharmacol. 1996 Jun;49(6):972-9. Mol Pharmacol. 1996. PMID: 8649357

4

Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues.

Macchia M, Barontini S, Bertini S, Di Bussolo V, Fogli S, Giovannetti E, Grossi E, Minutolo F, Danesi R. Macchia M, et al. Among authors: danesi r. J Med Chem. 2001 Nov 8;44(23):3994-4000. doi: 10.1021/jm010947r. J Med Chem. 2001. PMID: 11689086

5

Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity.

Macchia M, Antonello M, Bertini S, Di Bussolo V, Fogli S, Giovannetti E, Minutolo F, Rapposelli S, Danesi R. Macchia M, et al. Among authors: danesi r. Farmaco. 2003 Jan;58(1):85-9. doi: 10.1016/S0014-827X(02)00002-2. Farmaco. 2003. PMID: 12595041

6

Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.

Danesi R, de Braud F, Fogli S, de Pas TM, Di Paolo A, Curigliano G, Del Tacca M. Danesi R, et al. Pharmacol Rev. 2003 Mar;55(1):57-103. doi: 10.1124/pr.55.1.4. Pharmacol Rev. 2003. PMID: 12615954 Free article. Review.

7

Ceramide analogues in apoptosis: a new strategy for anticancer drug development.

Macchia M, Bertini S, Fogli S, Giovannetti E, Minutolo F, Rapposelli S, Danesi R. Macchia M, et al. Among authors: danesi r. Farmaco. 2003 Mar;58(3):205-11. doi: 10.1016/S0014-827X(03)00015-6. Farmaco. 2003. PMID: 12620416 Review.

8

Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.

Giovannetti E, Mey V, Danesi R, Mosca I, Del Tacca M. Giovannetti E, et al. Among authors: danesi r. Clin Cancer Res. 2004 May 1;10(9):2936-43. doi: 10.1158/1078-0432.ccr-03-0520. Clin Cancer Res. 2004. PMID: 15131028

9

Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine.

Bocci G, Danesi R, Marangoni G, Fioravanti A, Boggi U, Esposito I, Fasciani A, Boschi E, Campani D, Bevilacqua G, Mosca F, Del Tacca M. Bocci G, et al. Among authors: danesi r. Eur J Pharmacol. 2004 Sep 13;498(1-3):9-18. doi: 10.1016/j.ejphar.2004.07.062. Eur J Pharmacol. 2004. PMID: 15363970

10

Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.

Giovannetti E, Mey V, Danesi R, Basolo F, Barachini S, Deri M, Del Tacca M. Giovannetti E, et al. Among authors: danesi r. Br J Cancer. 2005 Feb 28;92(4):681-9. doi: 10.1038/sj.bjc.6602382. Br J Cancer. 2005. PMID: 15700043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters